These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3818091)

  • 1. Purification and biochemical properties of a bacteriocin from Actinobacillus actinomycetemcomitans.
    Stevens RH; Lillard SE; Hammond BF
    Infect Immun; 1987 Mar; 55(3):692-7. PubMed ID: 3818091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bacteriocin of Actinobacillus actinomycetemcomitans.
    Hammond BF; Lillard SE; Stevens RH
    Infect Immun; 1987 Mar; 55(3):686-91. PubMed ID: 3818090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of bacteriocin 28 produced by Clostridium perfringens.
    Li AW; Verpoorte JA; Lewis RG; Mahony DE
    Can J Microbiol; 1982 Jul; 28(7):860-73. PubMed ID: 6293695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and partial characterization of a 39 kDa major outer membrane protein of Actinobacillus actinomycetemcomitans Y4.
    Kokeguchi S; Kato K; Nishimura F; Kurihara H; Murayama Y
    FEMS Microbiol Lett; 1991 Jan; 61(1):85-9. PubMed ID: 2004699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and partial characterization of a bacteriocin isolated from Bacteroides ovatus H47.
    Miranda CM; Farias LM; Carvalho MA; Damasceno CA; Totola AH; Tavares CA; Cisalpino EO; Vieira EC
    Can J Microbiol; 1993 Feb; 39(2):169-74. PubMed ID: 8467417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B.
    Tsai CC; Shenker BJ; DiRienzo JM; Malamud D; Taichman NS
    Infect Immun; 1984 Feb; 43(2):700-5. PubMed ID: 6319288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracts of Prevotella intermedia and Actinobacillus actinomycetemcomitans inhibit alkaline phosphatase activity in osteoblastic cells in vitro.
    Murata T; Ansai T; Takehara T; Kobayashi S; Haneji T
    Oral Dis; 1997 Jun; 3(2):106-12. PubMed ID: 9467351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of a Corynebacterium ulcerans bacteriocin (ulceracin 378).
    Abrehem K; Zamiri I
    J Gen Microbiol; 1985 Apr; 131(4):707-13. PubMed ID: 3921657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of a fibroblast-inhibitory factor from Actinobacillus actinomycetemcomitans Y4.
    Kataoka M; Kawamura K; Kondoh T; Wakano Y; Ishida H
    FEMS Microbiol Lett; 1993 Feb; 107(1):111-4. PubMed ID: 8467993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a bacteriocin from Staphylococcus aureus strain 462.
    Hale EM; Hinsdill RD
    Antimicrob Agents Chemother; 1973 Dec; 4(6):634-40. PubMed ID: 4793882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural proteins of the Actinobacillus actinomycetemcomitans bacteriophage phi Aa.
    Stevens RH; Hammond BF; Fine DH
    Oral Microbiol Immunol; 1990 Aug; 5(4):213-8. PubMed ID: 2082245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Purification and characterization of sanguicin--a bacteriocin produced by Streptococcus sanguis].
    Deng H; Ding Y; Fu MD; Xiao XR; Liu J; Zhou T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):555-8. PubMed ID: 15291127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular fatty acid and soluble protein composition of Actinobacillus actinomycetemcomitans and related organisms.
    Calhoon DA; Mayberry WR; Slots J
    J Clin Microbiol; 1981 Oct; 14(4):376-82. PubMed ID: 7287893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophoretic heterogeneity of lipopolysaccharides of Actinobacillus actinomycetemcomitans.
    Hoover CI
    J Dent Res; 1988 Mar; 67(3):574-6. PubMed ID: 2459168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and purification of bacteriocin from Prevotella intermedia (Bacteroides intermedius).
    Takada K; Hirasawa M; Ikeda T
    J Periodontol; 1991 Jul; 62(7):439-44. PubMed ID: 1920011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Purification and characterization of "Clostridium perfringens" BP6K-N5 strain bacteriocin N5 (author's transl)].
    Wolff A; Ionesco H
    Ann Microbiol (Paris); 1975; 126(3):343-56. PubMed ID: 174471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of a bacteriocin from Klebsiella pneumoniae 158.
    Chhibber S; Vadehra DV
    J Gen Microbiol; 1986 Apr; 132(4):1051-4. PubMed ID: 3531394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of bacteriocin LS1 produced by human oral isolate Lactobacillus salivarius BGHO1.
    Busarcevic M; Kojic M; Dalgalarrondo M; Chobert JM; Haertlé T; Topisirovic L
    Oral Microbiol Immunol; 2008 Jun; 23(3):254-8. PubMed ID: 18402613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of two bacteriocins produced by Clostridium perfringens.
    Higa A; Yoshida E; Miyoshi Y
    Microbiol Immunol; 1991; 35(6):411-21. PubMed ID: 1921758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification, properties, and cytotoxic effect of a bacteriocin from Mycobacterium smegmatis.
    Saito H; Watanabe T; Tomioka H
    Antimicrob Agents Chemother; 1979 Apr; 15(4):504-9. PubMed ID: 464582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.